Clinical trial participants are given the advantage of receiving innovative treatment from expert physicians at no cost, all while helping advance medical science. In most clinical trials, participants will receive compensation for their time and travel costs.

Windom Allergy operates clinical trials through Sarasota Clinical Research, allowing patients access to new treatment options before they become widely available to the public. Sarasota Clinical Research participants perform a series of clinical trials, testing investigational drugs with the potential to become FDA approved medicine.

While the majority of Sarasota Clinical Research trials involve investigational drugs for asthma, COPD, and emphysema, we also conduct clinical trials related to food allergy, allergic rhinitis, and hives. We currently have patients enrolled in clinical trials for the first peanut allergy products: an oral capsule of peanut flour used in an Oral Immunotherapy protocol, and a peanut patch which adheres to the patient. 

Since we began Sarasota Clinical Research in 1994, numerous medications involved in our clinical trials have been approved by the FDA, including: Nasonex®, Advair®, Symbicort®, Xolair®, Spiriva®, Foradil®, Asmanex®, Omnaris®, Tekturna®, Dulera®, Tudorza®, Pressair®, Onbrez®, and Perforomist®. 

To enroll in a clinical trial at Windom Allergy, email This email address is being protected from spambots. You need JavaScript enabled to view it. or call 941-927-4888 today.